Bellerophon Therapeutics (BLPH, $0.04) gained and reached a new high over the last three months. By comparison, the broader Biotechnology Industry returned 1 over the same period of time. A.I.dvisor analyzed 839 stocks in the Biotechnology Industry over the same period of time and found that of them (5) were in an Uptrend while of them (4) showed a Downtrend.